FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.10 | FHIR Version n/a User: [n/a]

37613111000001104: Levetiracetam 250mg tablets (Crescent Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Levetiracetam 250mg tablets (Crescent Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely levetiracetam 250 milligram/1 each conventional release oral tablet\Levetiracetam 250mg tablets (Crescent Pharma Ltd)
\UK product\Virtual therapeutic moiety\Levetiracetam\Product containing only levetiracetam in oral dose form (medicinal product form)\Product containing precisely levetiracetam 250 milligram/1 each conventional release oral tablet\Levetiracetam 250mg tablets (Crescent Pharma Ltd)
\UK product\Virtual therapeutic moiety\Levetiracetam\Product containing precisely levetiracetam 250 milligram/1 each conventional release oral tablet\Levetiracetam 250mg tablets (Crescent Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Sep 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

379371000001114 Levetiracetam 250mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

379381000001111 Levetiracetam 250mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Is a	Product containing precisely levetiracetam 250 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Has specific active ingredient	Levetiracetam	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Levetiracetam 250mg tablets (Crescent Pharma Ltd) 60 tablet 6 x 10 tablets	Has AMP	True	Levetiracetam 250mg tablets (Crescent Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
379371000001114	Levetiracetam 250mg tablets (Crescent Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
379381000001111	Levetiracetam 250mg tablets (Crescent Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module